„Mastering the New Time Pressure on Human Pharmacology“ – a burning issue for all of us being active in early drug development. Therefore, the 4th EUFEMED conference hits a key point we at SocraTec R&D are dealing with every day. Therefore, it is more than expected that we are there.
The practical implications of risk assessment for FIH as well as early inclusion of patients in clinical development fully matches with our daily work and therefore are burning topics for us and our clients. But also buzz words like digitalisation, human challenge studies, innovative Proof-of-Mechanism designs raise the curiosity and underline why you should also be there.